Dynavax and Times Pharmacy Announce Partnership to Offer HEPLISAV-B® Hepatitis B Vaccine to Customers Throughout Oahu, with a Focus on People with DiabetesGlobeNewsWire • 07/10/20
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't?Zacks Investment Research • 07/07/20
Why Novavax, Dynavax, VBI Vaccines, and Co-Diagnostics Stocks Are Jumping TodayThe Motley Fool • 06/25/20
Dynavax Announces First Participants Dosed in Phase 1 Clinical Trial Evaluating Clover Biopharmaceuticals’ COVID-19 S-Trimer Vaccine Candidate with CpG 1018 AdjuvantGlobeNewsWire • 06/19/20
Dynavax Completes Enrollment of Clinical Trial Evaluating HEPLISAV-B in Patients Undergoing HemodialysisGlobeNewsWire • 06/09/20
Implied Volatility Surging for Dynavax Technologies (DVAX) Stock OptionsZacks Investment Research • 05/29/20
Dynavax Technologies Announces Closing of $80.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewsWire • 05/27/20